Swiss medicine regulator warns against purchase of fake Ozempic
Ozempic is approved in Switzerland for people with type-2 diabetes and can be used as "off label" for weight loss.
Copyright 2023 The Associated Press. All Rights Reserved.
Swissmedic has warned against buying drugs from unreliable sources, particularly from abroad, after reports of hospitalisations in connection with falsified injectables of Ozempic. The medicine, which is approved to treat type 2 diabetes, has been touted as a weight-loss drug on social media.
This content was published on
2 minutes
swissinfo.ch/jdp
The individuals affected were admitted to hospital with acute hypoglycaemia (low blood sugar levels). In one case, an insulin pen had been packaged as an Ozempic pen. Hypoglycaemia triggered by an insulin overdose is life-threatening and must be treated immediately, wroteExternal link the Swiss drugs regulator.
Ozempic is authorised in Switzerland for type 2 diabetes, which is adult-onset diabetes. The drug, developed by the Danish company Novo Nordisk, can be used for weight loss if prescribed by a doctor for “off-label use”. In such a case, the drug must be used under medical supervision.
The active ingredient in Ozempic, semaglutide, is used at a higher dose in another drug, Wegovy, which Swissmedic has authorised for the treatment of obesity.
Semaglutide lowers blood sugar levels and regulates insulin, which is crucial for people with type 2 diabetes. It also imitates a hormone called GLP-1, which can suppress appetite.
Demand for Ozempic skyrocketed after several celebrities and TikTok influencers touted the drug – which is administered as a self-injectable pen – as a way to lose weight in a short time. Due to high demand, falsifications of these products are increasingly appearing internationally, indicated the regulator.
Swissmedic said it “urgently warns against purchasing and using unathorised medicines offered in printed advertisements, promotional e-mails or via websites.”
Popular Stories
More
Swiss Abroad
Heimatort, sweet Heimatort: the unique Swiss concept of home
As a Swiss Abroad, how do you feel about the emergence of more conservative family policies in some US states?
In recent years several US states have adopted more conservative policies on family issues, abortion and education. As a Swiss citizen living there, how do you view this development?
What factors should be taken into account when inheriting Swiss citizenship abroad?
Should there be a limit to the passing on of Swiss citizenship? Or is the current practice too strict and it should still be possible to register after the age of 25?
Over a quarter of Swiss Catholics consider leaving the church
This content was published on
In Switzerland 27% of Catholics have thought about leaving the church, according to a survey by the Sotomo research centre.
This content was published on
Following the Credit Suisse debacle, the Swiss Financial Market Supervisory Authority (FINMA) is adapting its organisation.
This content was published on
The Swiss Armed Forces are training their fighter jets in Bern to fly from a civilian base. The exercise at Bern Airport will last until Wednesday.
Plans materialise for new particle accelerator in Geneva
This content was published on
Preparations for a huge new particle accelerator in Geneva have reached a milestone. After several years of work, a feasibility study for the project has now been finalised.
This content was published on
The value of frozen Russian assets in Switzerland currently stands at CHF7.4 billion ($8.4 billion), the Swiss government announced on Tuesday.
This content was published on
The number of business start-ups in Switzerland accelerated in the first three months of the year, with entrepreneurs being particularly dynamic in Central Switzerland, Basel and Geneva.
Most Swiss authorities want to ban Nazi symbols in public
This content was published on
A majority of Swiss political parties, cantons and associations want to ban the use and distribution of Nazi symbols in public.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Novartis sets sights on high-value medicines and US market
This content was published on
Swiss pharma giant Novartis has unveiled an updated strategy focused on high-value medicines and boosting its position in the US market.
Swiss alliance calls for obesity to be recognised as a disease
This content was published on
The Swiss Obesity Alliance wants to classify obesity as a disease in the revision of the national strategy on “non-communicable diseases”.
This content was published on
Swiss experts have stepped up their warnings about slimming aids bought over the internet. Some have shown a high level of the potentially fatal substance.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.